Structure-dependent immunostimulatory effect of CpG oligodeoxynucleotides and their delivery system
about
CpG oligodeoxynucleotides as mucosal adjuvantsImmune-Stimulatory Dinucleotide at the 5'-End of Oligodeoxynucleotides Is Critical for TLR9-Mediated Immune Responses.Epigallocatechin-3-gallate suppresses proinflammatory cytokines and chemokines induced by Toll-like receptor 9 agonists in prostate cancer cells.Enhancing mucosal immunity in mice by recombinant adenovirus expressing major epitopes of porcine circovirus-2 capsid protein delivered with cytosine-phosphate-guanosine oligodeoxynucleotidesTLR3 and TLR9 agonists improve postexposure vaccination efficacy of live smallpox vaccines.Optically Triggered Immune Response through Photocaged Oligonucleotides.Polyethyleneimine-functionalized boron nitride nanospheres as efficient carriers for enhancing the immunostimulatory effect of CpG oligodeoxynucleotides.Mechanism of Mitochondrial Transcription Factor A Attenuation of CpG-Induced Antibody Production.Effects of CpG oligodeoxynucleotide 1826 on acute radiation-induced lung injury in miceProgress Toward a Human Vaccine Against CoccidioidomycosisEffects of CpG Oligodeoxynucleotide 1826 on transforming growth factor-beta 1 and radiation-induced pulmonary fibrosis in micePleiotropic action of CpG-ODN on endothelium and macrophages attenuates angiogenesis through distinct pathways.Effect of amino groups of mesoporous silica nanoparticles on CpG oligodexynucleotide delivery.DNA-polymer conjugates for immune stimulation through Toll-like receptor 9 mediated pathways.Plant-based modulation of Toll-like receptors: an emerging therapeutic model.Influence of diverse chemical modifications on the ADME characteristics and toxicology of antisense oligonucleotides.Oligonucleotide conjugates for therapeutic applications.Immunotherapeutic potential of CpG oligodeoxynucleotides in veterinary species.Immunomodulatory oligonucleotides inhibit neutrophil migration by decreasing the surface expression of interleukin-8 and leukotriene B4 receptors.Polyethyleneimine is a potent systemic adjuvant for glycoprotein antigens.Identification of a boron nitride nanosphere-binding peptide for the intracellular delivery of CpG oligodeoxynucleotides.Optimisation of one-step desolvation and scale-up of gelatine nanoparticle production.Microfluidic generation of chitosan/CpG oligodeoxynucleotide nanoparticles with enhanced cellular uptake and immunostimulatory properties.Mesoporous silica nanoparticles for enhancing the delivery efficiency of immunostimulatory DNA drugs.VaccineDA: Prediction, design and genome-wide screening of oligodeoxynucleotide-based vaccine adjuvants.Forging a potent vaccine adjuvant: CpG ODN/cationic peptide nanorings.Species-dependent role of type I IFNs and IL-12 in the CTL response induced by humanized CpG complexed with β-glucan.Targeting of C-type lectin-like receptor 2 or P2Y12 for the prevention of platelet activation by immunotherapeutic CpG oligodeoxynucleotides: reply.CpG loaded MoS2 nanosheets as multifunctional agents for photothermal enhanced cancer immunotherapy.Development of CpG ODN Based Vaccine Adjuvant Formulations.Retardation of Antigen Release from DNA Hydrogel Using Cholesterol-Modified DNA for Increased Antigen-Specific Immune Response.Class-B CpG-ODN Formulated With a Nanostructure Induces Type I Interferons-Dependent and CD4 T Cell-Independent CD8 T-Cell Response Against Unconjugated Protein AntigenModified FeO Magnetic Nanoparticle Delivery of CpG Inhibits Tumor Growth and Spontaneous Pulmonary Metastases to Enhance Immunotherapy
P2860
Q28086998-9A1838F5-1534-4CA9-87B1-3F5B7A47B4FEQ33635971-DC76CF16-373B-4B96-BA7D-B7525CBD98CDQ33806328-D1673E54-AB83-41C6-B71E-4A947B3EFDCFQ34258568-BEFFB1B8-D5B6-4B44-BBC4-D3AD827CF53AQ34414790-9458F496-F263-4A10-988F-B1FBB79804ACQ35664282-D274F5CE-25CE-4A50-B5F9-42A5A7E55D2DQ36010351-08C45EFD-3871-400D-A335-91E4AE4E23D3Q36046749-39984C71-F172-46FF-840C-9A5AE16E2A03Q36538093-61FAE3FB-8257-48EB-8ECB-12A69251910FQ36749818-52ECA6AC-28CA-4E54-95B2-B65992B96CB0Q36907395-49412AEC-962E-47E9-9A40-1BBDDDCE2241Q37202398-65380247-D9E7-4E03-8C04-3352280EFB05Q37386082-EC50703B-F2EE-4DFE-9DC5-D453A79D3B7EQ37589660-82FB5511-0F0B-4414-9370-D942DC716CF8Q38059461-B5C44140-4CDA-4051-8FA9-B23385E2F667Q38085679-8BA74281-E7CF-441A-B047-06728E17D09FQ38123854-195F75F7-AF9A-4CAF-ADFD-F58AE4A6F642Q38131836-5E9E7276-E0FD-484F-A579-4349033D1D54Q38305188-4361722B-25DA-4248-9A66-2D0DFA838618Q38306977-90C80FF7-D30C-4779-8959-E5DB5D63E924Q38322106-D3B9FD40-125F-4CBF-9520-EECA023C4BEAQ38828332-CAFC7244-26AB-4880-87C3-5E024CC50952Q39004122-93839868-A643-44FC-A350-98BA1E88D675Q39027270-BB93BBC3-1A2D-4F79-81E5-17FCA34B8C23Q40694695-144822D7-262E-48CB-9309-37081946B666Q43103503-E78B2C5A-249C-46B9-8BC5-044038947FFAQ46608381-CEB74D32-6296-44F1-80C5-F6BDE07C88B5Q50101374-CC94C137-2B15-4364-8667-FAF812DF0D3FQ50653775-2BBC76C0-ACBB-48BB-96D7-B216047EE727Q50656129-170E76B7-C930-4ED6-82B6-7DD4A9678083Q54712417-185D0F70-BC25-49D7-9D22-6BA288B1E5B2Q58575827-A0762D8A-1762-4EC1-898C-905034E0549AQ58771490-389F474C-D4F1-4CA1-B690-B556968F7F7C
P2860
Structure-dependent immunostimulatory effect of CpG oligodeoxynucleotides and their delivery system
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Structure-dependent immunostim ...... ides and their delivery system
@ast
Structure-dependent immunostim ...... ides and their delivery system
@en
Structure-dependent immunostim ...... ides and their delivery system
@nl
type
label
Structure-dependent immunostim ...... ides and their delivery system
@ast
Structure-dependent immunostim ...... ides and their delivery system
@en
Structure-dependent immunostim ...... ides and their delivery system
@nl
prefLabel
Structure-dependent immunostim ...... ides and their delivery system
@ast
Structure-dependent immunostim ...... ides and their delivery system
@en
Structure-dependent immunostim ...... ides and their delivery system
@nl
P2860
P3181
P356
P1476
Structure-dependent immunostim ...... ides and their delivery system
@en
P2093
Nobutaka Hanagata
P2860
P304
P3181
P356
10.2147/IJN.S30197
P407
P577
2012-01-01T00:00:00Z
2012-04-27T00:00:00Z